Fact sheet

EQS-News: EcoGraf recognised by MSP in US Press Release

Retrieved on: 
Wednesday, March 13, 2024
Prospectors, FMK, Innovation, Next Generation, MSP, KfW IPEX-Bank, Partnership, Fact sheet, KfW, ASX, EGR, PDAC, Mineral, Security (finance)

EcoGraf Limited (EcoGraf or the Company) (ASX: EGR; FSE: FMK; OTCQB: ECGFF) is pleased to report that its Epanko Graphite Project is recognised in a recent Joint Statement of the Minerals Security Partnership (MSP) issued by the US Department of State.

Key Points: 
  • EcoGraf Limited (EcoGraf or the Company) (ASX: EGR; FSE: FMK; OTCQB: ECGFF) is pleased to report that its Epanko Graphite Project is recognised in a recent Joint Statement of the Minerals Security Partnership (MSP) issued by the US Department of State.
  • The press release recognises EcoGraf’s recent significant milestone in securing German-based KfW IPEX-Bank to arrange a senior debt facility of up to US$105 million for the development of stage 1 of the Company’s Epanko Graphite Project in Tanzania.
  • This statement follows MSP principals’ meeting in Toronto during the recent Prospectors and Developers Association of Canada  (PDAC) annual convention, one of the largest mining events in the world.
  • The theme of the principals’ meeting was responsible investment in critical minerals, with the key objective to strengthen collaboration between the MSP and like-minded partners.

Sunnyside Renewable Natural Gas Project Moving Forward

Retrieved on: 
Monday, January 29, 2024
CO2, Natural gas, Port, Farmer, City, RNG, Methane, Manure, Plant, Fact sheet, Dairy

SUNNYSIDE, Wash., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The proposed Sunnyside Renewable Natural Gas facility has completed the Washington State Environmental Policy Act (SEPA) process, a comprehensive environmental assessment which includes input from relevant regulators and stakeholders including the Washington State Department of Ecology, City of Sunnyside and the local community.

Key Points: 
  • SUNNYSIDE, Wash., Jan. 29, 2024 (GLOBE NEWSWIRE) -- The proposed Sunnyside Renewable Natural Gas facility has completed the Washington State Environmental Policy Act (SEPA) process, a comprehensive environmental assessment which includes input from relevant regulators and stakeholders including the Washington State Department of Ecology, City of Sunnyside and the local community.
  • Based on the favorable conclusion of this process, Pacific Ag Renewables is moving the project forward.
  • Located on approximately 50 acres in the Port of Sunnyside Industrial Park, Sunnyside RNG will produce approximately 900,000 MMBtu of RNG per year, enough to power roughly 90,000 homes.
  • Sunnyside RNG will divert dairy manure that otherwise would enter lagoons and produce renewable natural gas that will replace fossil-based fuels for home heating and trucking fleets.

Regu(AI)ting Health: Lessons for Navigating the Complex Code of AI and Healthcare Regulations

Retrieved on: 
Wednesday, January 24, 2024
Risk management, OCR, Legislation, Research, Artificial intelligence, Drug discovery, Advertising, Felicity, Documentation, AI safety, HHS, Blueprint, EO, Commission, Privacy, HIPAA, Data management, CDRH, Policy, Accountability Act, Consumer, DOJ, Plan, Software, Device, Department, CFPB, Safety, Drug development, Organization, Technology policy, Failure, Civil and political rights, Security, AI, NIST, BetterHelp, National, Federal Trade Commission, EEOC, OSTP, White, GoodRx, Exercise, Catalog, FTC, Patient, Action plan, Intelligence, Equal opportunity, Bias, Ecosystem, Federation, Medical device, Food, OMB, FDA, National Institute, Management, Fact sheet, Internet of things

Authors: Stephanie Wong, Amber Ezzell, & Felicity Slater As an increasing number of organizations utilize artificial intelligence (“AI”) in their patient-facing services, health organizations are seizing the opportunity to take advantage of the new wave of AI-powered tools. Policymakers, from United States (“U.S.”) government agencies to the White House, have taken heed of this trend, [?]

Key Points: 


Authors: Stephanie Wong, Amber Ezzell, & Felicity Slater As an increasing number of organizations utilize artificial intelligence (“AI”) in their patient-facing services, health organizations are seizing the opportunity to take advantage of the new wave of AI-powered tools. Policymakers, from United States (“U.S.”) government agencies to the White House, have taken heed of this trend, [?]

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Retrieved on: 
Tuesday, October 3, 2023
EUA, Heart, Pregnancy, Pharmacy, Caregiver, Tell, Arthralgia, Vaccination, Chills, Rite Aid, Infection, Fever, COVID-19, Center for Biologics Evaluation and Research, Coronavirus, Skin, Drug testing welfare recipients, Woman, COVID, Inflammation, Fact sheet, CVS Pharmacy, Government, CDC, Myalgia, Vomiting, Formula, Allergy, Physician, Child, XBB, Korea Disease Control and Prevention Agency, Immune system, USE, VAERS, Nausea, NVAX, European Medicines Agency, Ageing, FDA, Headache, Death, Regulation of tobacco by the U.S. Food and Drug Administration, FD, Food, World Health Organization, Fatigue, Pericarditis, Vaccine, Pharmaceutical industry, Birth control, Medical device, Mobile phone, Novavax COVID-19 vaccine, Hypoesthesia, Adjuvant, Novavax

In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."

Key Points: 
  • In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."
  • What should you mention to your vaccination provider before you or your child get the Novavax COVID-19 Vaccine, Adjuvanted?
  • A person should not get the Novavax COVID-19 Vaccine, Adjuvanted if they had:
    a severe allergic reaction after a previous dose of any Novavax COVID-19 Vaccine, Adjuvanted
    What are the risks of the Novavax COVID-19 Vaccine, Adjuvanted?
  • Women who are vaccinated with the Novavax COVID-19 Vaccine, Adjuvanted during pregnancy are encouraged to enroll in the registry by visiting https://c-viper.pregistry.com .

Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.

Retrieved on: 
Tuesday, October 3, 2023
EUA, Heart, Pregnancy, Pharmacy, Caregiver, Tell, Arthralgia, Vaccination, Chills, Rite Aid, Infection, Fever, COVID-19, Center for Biologics Evaluation and Research, Coronavirus, Skin, Drug testing welfare recipients, Woman, COVID, Inflammation, Fact sheet, CVS Pharmacy, Government, CDC, Myalgia, Vomiting, Formula, Allergy, Physician, Child, XBB, Korea Disease Control and Prevention Agency, Immune system, USE, VAERS, Nausea, NVAX, European Medicines Agency, Ageing, FDA, Headache, Death, Regulation of tobacco by the U.S. Food and Drug Administration, FD, Food, World Health Organization, Fatigue, Pericarditis, Vaccine, Pharmaceutical industry, Birth control, Medical device, Mobile phone, Novavax COVID-19 vaccine, Hypoesthesia, Adjuvant, Novavax

In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."

Key Points: 
  • In the coming days, individuals in the U.S. can go to pharmacies, physicians' offices, clinics and various government entities to receive an updated Novavax vaccine."
  • What should you mention to your vaccination provider before you or your child get the Novavax COVID-19 Vaccine, Adjuvanted?
  • A person should not get the Novavax COVID-19 Vaccine, Adjuvanted if they had:
    a severe allergic reaction after a previous dose of any Novavax COVID-19 Vaccine, Adjuvanted
    What are the risks of the Novavax COVID-19 Vaccine, Adjuvanted?
  • Women who are vaccinated with the Novavax COVID-19 Vaccine, Adjuvanted during pregnancy are encouraged to enroll in the registry by visiting https://c-viper.pregistry.com .

AGBA Group Holding Limited (NASDAQ: ‘AGBA’) releases updated materials for its new and existing investors

Retrieved on: 
Friday, April 14, 2023
Insurance, Coronavirus, Ng, Fact sheet, Public expenditure, Acquisition, Management, Cryptocurrency, Renewable energy, Risk management

The release of these in-depth investor materials underscores AGBA's ongoing commitment to transparency and its dedication to providing valuable resources to investors.

Key Points: 
  • The release of these in-depth investor materials underscores AGBA's ongoing commitment to transparency and its dedication to providing valuable resources to investors.
  • The pack includes a detailed review of the Group's valuation prospects, highlighting the company's significant growth potential.
  • Wing-Fai Ng, Group President, AGBA Group Holding Limited said, “This valuable resource is a testament to our commitment to transparency and reliability in providing information to the public.
  • For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release.

Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™

Retrieved on: 
Wednesday, November 16, 2022
COVID-19, Growth, Patient, Hospital, GSK, SAN, Drug development, Hepatitis D, Immune system, Hepatitis B, Food, Health care, Caregiver, Risk, Safety, EUA, Emergency Use Authorization, Omicron, Bill, Deloitte Technology Fast 500, Fact sheet, Fact, HIV, National Accreditation Board for Hospitals & Healthcare Providers, Infection, Telecommunication, Letter, Federal Food, Drug, and Cosmetic Act, Death, Research, Bill & Melinda Gates Foundation, Severe acute respiratory syndrome coronavirus 2, FDA, Vaccine, Pharmaceutical industry, Dietary supplement, Parent

Now in its 28th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies both public and private in North America.

Key Points: 
  • Now in its 28th year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech and energy tech companies both public and private in North America.
  • Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2018 to 2021.
  • Additionally, companies must be in business for a minimum of four years and be headquartered within North America.
  • Vir Biotechnologyis a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.

DFIN ESG Fact Sheet Helps Companies Jumpstart Their ESG Journey

Retrieved on: 
Wednesday, November 16, 2022
SEC, Goal, Climate change, American Outdoor Brands, Inc., Compliance, Environment, ESG, Data management, Biophysical environment, Donnelley Financial Solutions, Investor relations, Time, NYSE, Social, Multimedia, Social Security Government Pension Offset, Fact sheet, Risk, Sustainability Accounting Standards Board, Lithium, Risk management

NEW YORK, Nov. 16, 2022 /PRNewswire/ -- Donnelley Financial Solutions (NYSE: DFIN), a leading risk and compliance company, announced today that it is offering the DFIN ESG Fact Sheet to help companies streamline and simplify Environmental, Social and Governance (ESG) data management and reporting.  This enterprise reporting software solution helps companies reduce reporting costs while demonstrating to stakeholders a commitment to ESG policies. Based on Sustainability Accounting Standard Board (SASB) guidelines, it enables companies to address the evolving nature of ESG reporting in a timely, affordable, and efficient manner.

Key Points: 
  • This enterprise reporting software solution helps companies reduce reporting costs while demonstrating to stakeholders a commitment to ESG policies.
  • DFIN's ESG Fact Sheet solution, developed and based on numerous DFIN customer engagements and years of expertise, makes it easy for companies to deliver ESG reports typically in 90 days.
  • The resulting ESG Fact Sheet serves several functions:
    Informing employees and investors how a company addresses its ESG goals.
  • Companies using the DFIN ESG Fact Sheet can easily highlight improvements in ESG compliance over time and reduce their reporting costs by streamlining the entire process."

Pfizer Presents Scientific Advancements in Infectious Disease Prevention and Treatments at IDWeek 2022

Retrieved on: 
Tuesday, October 18, 2022
Health, Infectious Diseases, COVID-19, Research, Science, Pharmaceutical, Biotechnology, Risk, Health care, Subtypes of HIV, Anaphylaxis, Cystic fibrosis, Jaundice, Patient, Hepatitis, Initiation, Fact sheet, HIV-1, Stevens–Johnson syndrome, HIV, Hepatotoxicity, Drug, Plasma, HIV-1 protease, Ritonavir, CYP3A, Dysgeusia, Pharmaceutical industry

Drugs listed in Table 1 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.

Key Points: 
  • Drugs listed in Table 1 are a guide and not considered a comprehensive list of all possible drugs that may interact with PAXLOVID.
  • Cases of Toxic Epidermal Necrolysis and Stevens-Johnson syndrome have been reported with ritonavir, a component of PAXLOVID (refer to NORVIR prescribing information).
  • Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
  • Pfizer assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.

GREENHECK SUPPORTS HEALTHY INDOOR AIR IN SCHOOLS

Retrieved on: 
Monday, October 3, 2022
IAQ, Solution, School, Ventilation, Student, FAX, AMCA, International, White, DOAS, Filtration, Engineering, Certification, Health, Sound, Heat, COVID-19, Post office box, American Rescue Plan Act of 2021, Fact sheet, Aerosol, HVAC, Atmosphere, Risk, Air conditioning, White House, Carbon, Air Movement and Control Association, Fluid, FEI, Heating, ventilation, and air conditioning

SCHOFIELD, Wis., Oct. 3, 2022 /PRNewswire/ -- A recently released White House Fact Sheet, Back to School 2022: Giving Every School the Tools to Prevent COVID-19 Spread and Stay Safely Open All Year Long, cites improving indoor air quality across America's school buildings through effective ventilation and filtration as an important part of COVID-19 prevention. In addition to other layered prevention strategies, taking action to improve indoor air quality can also reduce the risk of exposure to particles, aerosols, and other contaminants, and improve the health of building occupants. Proper ventilation and good indoor air quality have also been shown to improve student academic performance in schools. 

Key Points: 
  • Greenheck is in a unique position to support school districts seeking to improve their heating, ventilation, and air conditioning (HVAC) systems to improve indoor air quality (IAQ) in their buildings.
  • In addition to helping schools plan and implement indoor air quality improvements, including through the use of federal funds, the sheet also encourages connecting schools with experts to provide support for indoor air quality.
  • "Ventilation is a necessity and we need to shift the narrative from indoor air quality to indoor air safety.
  • Greenheck and its nationwide network of manufacturer's representatives are ready to help schools plan and implement energy-saving indoor air quality improvements.